摘要
Colorectal cancer is one of the few malignant tumors in which synchronous or metachronous liver metastases [colorectal liver metastases(CRLMs)] may be treated with surgery. It has been demonstrated that resection of CRLMs improves the long-term prognosis. On the other hand, patients with un-resectable CRLMs may benefit from chemotherapy alone or in addition to liverdirected therapies. The choice of the most appropriate therapeutic management of CRLMs depends mostly on the diagnostic imaging. Nowadays, multiple non-invasive imaging modalities are available and those have a pivotal role in the workup of patients with CRLMs. Although extensive research has been performed with regards to the diagnostic performance of ultrasonography, computed tomography, positron emission tomography and magnetic resonance for the detection of CRLMs, the optimal imaging strategies for staging and follow up are still to be established. This largely due to the progressive technological and pharmacological advances which are constantly improving the accuracy of each imaging modality. This review describes the non-invasive imaging approaches of CRLMs reporting the technical features, the clinical indications, the advantages and the potential limitations of each modality, as well as including some information on the development of new imaging modalities, the role of new contrast media and the feasibility of using parametric image analysis as diagnostic marker of presence of CRLMs.
Colorectal cancer is one of the few malignant tumors in which synchronous or metachronous liver metastases [colorectal liver metastases(CRLMs)] may be treated with surgery. It has been demonstrated that resection of CRLMs improves the long-term prognosis. On the other hand, patients with un-resectable CRLMs may benefit from chemotherapy alone or in addition to liverdirected therapies. The choice of the most appropriate therapeutic management of CRLMs depends mostly on the diagnostic imaging. Nowadays, multiple non-invasive imaging modalities are available and those have a pivotal role in the workup of patients with CRLMs. Although extensive research has been performed with regards to the diagnostic performance of ultrasonography, computed tomography, positron emission tomography and magnetic resonance for the detection of CRLMs, the optimal imaging strategies for staging and follow up are still to be established. This largely due to the progressive technological and pharmacological advances which are constantly improving the accuracy of each imaging modality. This review describes the non-invasive imaging approaches of CRLMs reporting the technical features, the clinical indications, the advantages and the potential limitations of each modality, as well as including some information on the development of new imaging modalities, the role of new contrast media and the feasibility of using parametric image analysis as diagnostic marker of presence of CRLMs.
引文
1 American Cancer Society.Cancer Facts&Figures 2014.Atlanta:American Cancer Society,2014.[Accessed 2014 Jan 21].Available from:URL:http://www.cancer.org/research/cancerfactsstatistics/index
2 Manfredi S,Lepage C,Hatem C,Coatmeur O,Faivre J,Bouvier AM.Epidemiology and management of liver metastases from colorectal cancer.Ann Surg 2006;244:254-259[PMID:16858188DOI:10.1097/01.sla.0000217629.94941.cf]
3 Kanas GP,Taylor A,Primrose JN,Langeberg WJ,Kelsh MA,Mowat FS,Alexander DD,Choti MA,Poston G.Survival after liver resection in metastatic colorectal cancer:review and metaanalysis of prognostic factors.Clin Epidemiol 2012;4:283-301[PMID:23152705 DOI:10.2147/CLEP.S34285]
4 Simmonds PC,Primrose JN,Colquitt JL,Garden OJ,Poston GJ,Rees M.Surgical resection of hepatic metastases from colorectal cancer:a systematic review of published studies.Br J Cancer 2006;94 :982-999[PMID:16538219 DOI:10.1038/sj.bjc.6603033]
5 Tzeng CW,Aloia TA.Colorectal liver metastases.J Gastrointest Surg 2013;17:195-201;quiz p.201-202[PMID:23054896 DOI:10 .1007/s11605-012-2022-3]
6 Fong Y,Cohen AM,Fortner JG,Enker WE,Turnbull AD,Coit DG,Marrero AM,Prasad M,Blumgart LH,Brennan MF.Liver resection for colorectal metastases.J Clin Oncol 1997;15:938-946[PMID:9060531]
7 Nakamura S,Suzuki S,Baba S.Resection of liver metastases of colorectal carcinoma.World J Surg 1997;21:741-747[PMID:9276706 DOI:10.1007/s002689900300]
8 Alberts SR,Poston GJ.Treatment advances in liver-limited metastatic colorectal cancer.Clin Colorectal Cancer 2011;10:258 -265[PMID:21820974 DOI:10.1016/j.clcc.2011.06.008]
9 Tanada M,Saeki T,Takashima S,Mogami H,Hyoudou I,Jinno K.[Intrahepatic arterial infusion chemotherapy for the colon cancer patients with liver metastases--a comparison of arterial embolization chemotherapy versus continuous arterial infusion chemotherapy].Gan To Kagaku Ryoho 1996;23:1440-1442[PMID:8854774]
10 Dodd GD,Soulen MC,Kane RA,Livraghi T,Lees WR,Yamashita Y,Gillams AR,Karahan OI,Rhim H.Minimally invasive treatment of malignant hepatic tumors:at the threshold of a major breakthrough.Radiographics 2000;20:9-27[PMID:10682768DOI:10.1148/radiographics.20.1.g00ja019]
11 Ruers T,Bleichrodt RP.Treatment of liver metastases,an update on the possibilities and results.Eur J Cancer 2002;38:1023-1033[PMID:11978527]
12 Clavien PA,Petrowsky H,De Oliveira ML,Graf R.Strategies for safer liver surgery and partial liver transplantation.N Engl J Med2007;356:1545-1559[PMID:17429086]
13 Shah KN,Clary BM.Selection of Patients with Colorectal/Liver Metastases for Surgical Intervention:Current Issues and Challenges.Curr Surg Rep 2014;2:1-7[DOI:10.1007/s40137-014-0065-y]
14 Catalano OA,Singh AH,Uppot RN,Hahn PF,Ferrone CR,SahaniDV.Vascular and biliary variants in the liver:implications for liver surgery.Radiographics 2008;28:359-378[PMID:18349445 DOI:10 .1148/rg.282075099]
15 Kinkel K,Lu Y,Both M,Warren RS,Thoeni RF.Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods(US,CT,MR imaging,PET):a meta-analysis.Radiology 2002;224:748-756[PMID:12202709DOI:10.1148/radiol.2243011362]
16 Wernecke K,Rummeny E,Bongartz G,Vassallo P,Kivelitz D,Wiesmann W,Peters PE,Reers B,Reiser M,Pircher W.Detection of hepatic masses in patients with carcinoma:comparative sensitivities of sonography,CT,and MR imaging.AJR Am J Roentgenol 1991;157:731-739[PMID:1892027 DOI:10.2214/ajr.157.4.1892027]
17 Glover C,Douse P,Kane P,Karani J,Meire H,Mohammadtaghi S,Allen-Mersh TG.Accuracy of investigations for asymptomatic colorectal liver metastases.Dis Colon Rectum 2002;45:476-484[PMID:12006929]
18 Clarke MP,Kane RA,Steele G,Hamilton ES,Ravikumar TS,Onik G,Clouse ME.Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors.Surgery 1989;106:849-855[PMID:2554519]
19 Ohlsson B,Tranberg KG,Lundstedt C,Ekberg H,Hederstr?m E.Detection of hepatic metastases in colorectal cancer:a prospective study of laboratory and imaging methods.Eur J Surg 1993;159:275 -281[PMID:8103361]
20 Ong KO,Leen E.Radiological staging of colorectal liver metastases.Surg Oncol 2007;16:7-14[PMID:17499498]
21 Albrecht T,Hohmann J,Oldenburg A,Skrok J,Wolf KJ.Detection and characterisation of liver metastases.Eur Radiol2004;14 Suppl 8:P25-P33[PMID:15700330]
22 Albrecht T,Hoffmann CW,Schmitz SA,Schettler S,Overberg A,Germer CT,Wolf KJ.Phase-inversion sonography during the liverspecific late phase of contrast enhancement:improved detection of liver metastases.AJR Am J Roentgenol 2001;176:1191-1198[PMID:11312180 DOI:10.2214/ajr.176.5.1761191]
23 Albrecht T,Blomley MJ,Burns PN,Wilson S,Harvey CJ,Leen E,Claudon M,Calliada F,Correas JM,La Fortune M,Campani R,Hoffmann CW,Cosgrove DO,Le Fevre F.Improved detection of hepatic metastases with pulse-inversion US during the liverspecific phase of SHU 508A:multicenter study.Radiology 2003;227 :361-370[PMID:12649417 DOI:10.1148/radiol.2272011833]
24 Esteban JM,MolláMA,Tomás C,Maldonado L.Improved detection of liver metastases with contrast-enhanced wideband harmonic imaging:comparison with CT findings.Eur J Ultrasound2002;15:119-126[PMID:12423737 DOI:10.1016/S0929-8266(02)00032-0]
25 Quaia E,D’Onofrio M,Palumbo A,Rossi S,Bruni S,Cova M.Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver:diagnostic performance and confidence.Eur Radiol 2006;16:1599-1609[PMID:16552507DOI:10.1007/s00330-006-0192-7]
26 Dalla Palma L,Bertolotto M,Quaia E,Locatelli M.Detection of liver metastases with pulse inversion harmonic imaging:preliminary results.Eur Radiol 1999;9 Suppl 3:S382-S387[PMID:10602934 DOI:10.1007/PL00014079]
27 Celli N,Gaiani S,Piscaglia F,Zironi G,Camaggi V,Leoni S,Righini R,Bolondi L.Characterization of liver lesions by realtime contrast-enhanced ultrasonography.Eur J Gastroenterol Hepatol 2007;19:3-14[PMID:17206071 DOI:10.1097/01.meg.0000250585.53608.3c]
28 Larsen LP,Rosenkilde M,Christensen H,Bang N,Bolvig L,Christiansen T,Laurberg S.The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer:a prospective double-blinded study.Eur J Radiol 2007;62:302 -307[PMID:17194561 DOI:10.1016/j.ejrad.2006.11.033]
29 Westwood M,Joore M,Grutters J,Redekop K,Armstrong N,Lee K,Gloy V,Raatz H,Misso K,Severens J,Kleijnen J.Contrast-enhanced ultrasound using Sono Vue?(sulphur hexafluoride microbubbles)compared with contrast-enhanced computed tomography and contrastenhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases:a systematic review and cost-effectiveness analysis.Health Technol Assess 2013;17 :1-243[PMID:23611316 DOI:10.3310/hta17160]
30 Rafaelsen SR,Jakobsen A.Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer:a prospective,blinded,patient-by-patient analysis.Colorectal Dis 2011;13:420-425[PMID:20412096DOI:10.1111/j.1463-1318.2010.02288.x]
31 Cantisani V,Ricci P,Erturk M,Pagliara E,Drudi F,Calliada F,Mortele K,D’Ambrosio U,Marigliano C,Catalano C,Marin D,Di Seri M,Longo F,Passariello R.Detection of hepatic metastases from colorectal cancer:prospective evaluation of gray scale US versus Sono Vue?low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.Ultraschall Med 2010;31:500-505[PMID:20408122 DOI:10.1055/s-0028-1109751]
32 Larsen LP,Rosenkilde M,Christensen H,Bang N,Bolvig L,Christiansen T,Laurberg S.Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?Eur J Radiol 2009;69:308 -313[PMID:18068925 DOI:10.1016/j.ejrad.2007.10.023]
33 Konopke R,Bunk A,Kersting S.Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy.Ultraschall Med 2008;29 Suppl 4:S203-S209[PMID:18833498DOI:10.1055/s-2008-1027795]
34 Cantisani V,Grazhdani H,Fioravanti C,Rosignuolo M,Calliada F,Messineo D,Bernieri MG,Redler A,Catalano C,D’Ambrosio F.Liver metastases:Contrast-enhanced ultrasound compared with computed tomography and magnetic resonance.World J Gastroenterol 2014;20:9998-10007[PMID:25110428 DOI:10 .3748/wjg.v20.i29.9998]
35 Bolondi L.The appropriate allocation of CEUS in the diagnostic algorithm of liver lesions:a debated issue.Ultrasound Med Biol2013;39:183-185[PMID:23140590]
36 Choti MA,Sitzmann JV,Tiburi MF,Sumetchotimetha W,Rangsin R,Schulick RD,Lillemoe KD,Yeo CJ,Cameron JL.Trends in long-term survival following liver resection for hepatic colorectal metastases.Ann Surg 2002;235:759-766[PMID:12035031]
37 Rojas Llimpe FL,Di Fabio F,Ercolani G,Giampalma E,Cappelli A,Serra C,Castellucci P,D’Errico A,Golfieri R,Pinna AD,Pinto C.Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy:results of the PROMETEO-01study.Br J Cancer 2014;111:667-673[PMID:24983362 DOI:10 .1038/bjc.2014.351]
38 Niekel MC,Bipat S,Stoker J.Diagnostic imaging of colorectal liver metastases with CT,MR imaging,FDG PET,and/or FDG PET/CT:a meta-analysis of prospective studies including patients who have not previously undergone treatment.Radiology 2010;257 :674-684[PMID:20829538 DOI:10.1148/radiol.10100729]
39 Weg N,Scheer MR,Gabor MP.Liver lesions:improved detection with dual-detector-array CT and routine 2.5-mm thin collimation.Radiology 1998;209:417-426[PMID:9807568]
40 Kim YK,Ko SW,Hwang SB,Kim CS,Yu HC.Detection and characterization of liver metastases:16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging.Eur Radiol 2006;16:1337-1345[PMID:16453115 DOI:10.1007/s00330-005-0140-y]
41 Haider MA,Amitai MM,Rappaport DC,O’Malley ME,Hanbidge AE,Redston M,Lockwood GA,Gallinger S.Multi-detector row helical CT in preoperative assessment of small( 42 Kulinna C,Helmberger T,Kessler M,Reiser M.[Improvement in diagnosis of liver metastases with the multi-detector CT].Radiologe2001;41:16-23[PMID:11220094 DOI:10.1007/s001170050923]
43 Ch’en IY,Katz DS,Jeffrey RB,Daniel BL,Li KC,Beaulieu CF,Mindelzun RE,Yao D,Olcott EW.Do arterial phase helical CT images improve detection or characterization of colorectal livermetastases?J Comput Assist Tomogr 2011;21:391-397[PMID:9135646 DOI:10.1097/00004728-199705000-00010]
44 Wicherts DA,de Haas RJ,van Kessel CS,Bisschops RH,Takahara T,van Hillegersberg R,Bipat S,Rinkes IH,van Leeuwen MS.Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases:an evaluation with different reference standards.Eur J Radiol 2011;77:305-311[PMID:19695807 DOI:10 .1016/j.ejrad.2009.07.026]
45 Mainenti PP,Cirillo LC,Camera L,Persico F,Cantalupo T,Pace L,De Palma GD,Persico G,Salvatore M.Accuracy of single phase contrast enhanced multidetector CT colonography in the preoperative staging of colo-rectal cancer.Eur J Radiol 2006;60:453 -459[PMID:16965883 DOI:10.1016/j.ejrad.2006.08.001]
46 Bajpai SK,Sahani D.Recent progress in imaging of colorectal cancer liver metastases.Curr Colorectal Cancer Rep 2009;599 -107[DOI:10.1007/s11888-009-0015-8]
47 Berger-Kulemann V,Schima W,Baroud S,Koelblinger C,Kaczirek K,Gruenberger T,Schindl M,Maresch J,Weber M,BaSsalamah A.Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.Eur J Surg Oncol 2012;38:670-676[PMID:22652037 DOI:10.1016/j.ejso.2012.05.004]
48 Bipat S,Niekel MC,Comans EF,Nio CY,Bemelman WA,Verhoef C,Stoker J.Imaging modalities for the staging of patients with colorectal cancer.Neth J Med 2012;70:26-34[PMID:22271811]
49 Bipat S,van Leeuwen MS,Comans EF,Pijl ME,Bossuyt PM,Zwinderman AH,Stoker J.Colorectal liver metastases:CT,MR imaging,and PET for diagnosis--meta-analysis.Radiology 2005;237 :123-131[PMID:16100087 DOI:10.1148/radiol.2371042060]
50 Mainenti PP,Mancini M,MainolfiC,Camera L,Maurea S,Manchia A,Tanga M,Persico F,Addeo P,D’Antonio D,Speranza A,Bucci L,Persico G,Pace L,Salvatore M.Detection of colorectal liver metastases:prospective comparison of contrast enhanced US,multidetector CT,PET/CT,and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.Abdom Imaging 2010;35:511-521[PMID:19562412 DOI:10 .1007/s00261-009-9555-2]
51 Blyth S,Blakeborough A,Peterson M,Cameron IC,Majeed AW.Sensitivity of magnetic resonance imaging in the detection of colorectal liver metastases.Ann R Coll Surg Engl 2008;90:25-28[PMID:18201494 DOI:10.1308/003588408X242303]
52 Schima W,Saini S,Echeverri JA,Hahn PF,Harisinghani M,Mueller PR.Focal liver lesions:characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging.Radiology 1997;202:389-393[PMID:9015063]
53 Bennett GL,Petersein A,Mayo-Smith WW,Hahn PF,Schima W,Saini S.Addition of gadolinium chelates to heavily T2-weighted MR imaging:limited role in differentiating hepatic hemangiomas from metastases.AJR Am J Roentgenol 2000;174:477-485[PMID:10658728 DOI:10.2214/ajr.174.2.1740477]
54 Cittadini G,Santacroce E,Giasotto V,Rescinito G.[Focal liver lesions:characterization with quantitative analysis of T2 relaxation time in TSE sequence with double echo time].Radiol Med 2004;107 :166-173[PMID:15031682]
55 Patterson DM,Padhani AR,Collins DJ.Technology insight:water diffusion MRI--a potential new biomarker of response to cancer therapy.Nat Clin Pract Oncol 2008;5:220-233[PMID:18301415DOI:10.1038/ncponc1073]
56 Bruegel M,Holzapfel K,Gaa J,Woertler K,Waldt S,Kiefer B,Stemmer A,Ganter C,Rummeny EJ.Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique.Eur Radiol 2008;18:477-485[PMID:17960390 DOI:10.1007/s00330-007-0785-9]
57 Parikh T,Drew SJ,Lee VS,Wong S,Hecht EM,Babb JS,Taouli B.Focal liver lesion detection and characterization with diffusionweighted MR imaging:comparison with standard breath-hold T2-weighted imaging.Radiology 2008;246:812-822[PMID:18223123 DOI:10.1148/radiol.2463070432]
58 Kenis C,Deckers F,De Foer B,Van Mieghem F,Van Laere S,Pouillon M.Diagnosis of liver metastases:can diffusion-weighted imaging(DWI)be used as a stand alone sequence?Eur J Radiol 2012;81:1016-1023[PMID:21377305 DOI:10.1016/j.ejrad.2011.02.019]
59 Lwenthal D,Zeile M,Lim WY,Wybranski C,Fischbach F,Wieners G,Pech M,Kropf S,Ricke J,Dudeck O.Detection and characterisation of focal liver lesions in colorectal carcinoma patients:comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging.Eur Radiol 2011;21:832-840[PMID:20886339 DOI:10.1007/s00330-010-1977-2]
60 Bellin MF,Van Der Molen AJ.Extracellular gadolinium-based contrast media:an overview.Eur J Radiol 2008;66:160-167[PMID:18358659 DOI:10.1016/j.ejrad.2008.01.023]
61 del Frate C,Bazzocchi M,Mortele KJ,Zuiani C,Londero V,Como G,Zanardi R,Ros PR.Detection of liver metastases:comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.Radiology 2002;225:766-772[PMID:12461259 DOI:10.1148/radiol.2253011854]
62 Ward J,Robinson PJ,Guthrie JA,Downing S,Wilson D,Lodge JP,Prasad KR,Toogood GJ,Wyatt JI.Liver metastases in candidates for hepatic resection:comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging.Radiology 2005;237 :170-180[PMID:16126930 DOI:10.1148/radiol.2371041444]
63 Kim YK,Lee JM,Kim CS,Chung GH,Kim CY,Kim IH.Detection of liver metastases:gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging.Eur Radiol 2005;15:220-228[PMID:15624108 DOI:10 .1007/s00330-004-2570-3]
64 Maurea S,Mainenti PP,Tambasco A,Imbriaco M,Mollica C,Laccetti E,Camera L,Liuzzi R,Salvatore M.Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions:comparison between gadolinium and superparamagnetic iron oxide contrast media.Quant Imaging Med Surg 2014;4:181-189[PMID:24914419 DOI:10.3978/j.issn.2223-4292.2014.01.02]
65 Hamm B,Staks T,Mühler A,Bollow M,Taupitz M,Frenzel T,Wolf KJ,Weinmann HJ,Lange L.Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent:safety,pharmacokinetics,and MR imaging.Radiology 1995;195:785-792[PMID:7754011]
66 Dahlstrm N,Persson A,Albiin N,Smedby O,Brismar TB.Contrast-enhanced magnetic resonance cholangiography with GdBOPTA and Gd-EOB-DTPA in healthy subjects.Acta Radiol 2007;48 :362-368[PMID:17453513 DOI:10.1080/02841850701196922]
67 Auer RC,White RR,Kemeny NE,Schwartz LH,Shia J,Blumgart LH,Dematteo RP,Fong Y,Jarnagin WR,D’Angelica MI.Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy.Cancer 2010;116:1502-1509[PMID:20120032 DOI:10.1002/cncr.24912]
68 van Kessel CS,Buckens CF,van den Bosch MA,van Leeuwen MS,van Hillegersberg R,Verkooijen HM.Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy:a meta-analysis.Ann Surg Oncol 2012;19:2805-2813[PMID:22396005 DOI:10.1245/s10434-012-2300-z]
69 Tran PV,Jhaveri KS.Comparison of high spatial resolution respiratory triggered inversion recovery-prepared spoiled gradient echo sequence with standard breathhold T1 sequence MRI of the liver using gadoxetic acid.J Magn Reson Imaging 2013;37:700 -706[PMID:23335396 DOI:10.1002/jmri.23864]
70 Yoon JH,Lee JM,Lee ES,Baek J,Lee S,Iwadate Y,Han JK,Choi BI.Navigated three-dimensional T1-weighted gradient-echo sequence for gadoxetic acid liver magnetic resonance imaging in patients with limited breath-holding capacity.Abdom Imaging2015;40:278-288[PMID:25112454]
71 Ruers TJ,Langenhoff BS,Neeleman N,Jager GJ,Strijk S,Wobbes T,Corstens FH,Oyen WJ.Value of positron emission tomography with[F-18]fluorodeoxyglucose in patients withcolorectal liver metastases:a prospective study.J Clin Oncol 2002;20 :388-395[PMID:11786565 DOI:10.1200/JCO.20.2.388]
72 Rappeport ED,Loft A,Berthelsen AK,von der Recke P,Larsen PN,Mogensen AM,Wettergren A,Rasmussen A,Hillingsoe J,Kirkegaard P,Thomsen C.Contrast-enhanced FDG-PET/CT vs.SPIO-enhanced MRI vs.FDG-PET vs.CT in patients with liver metastases from colorectal cancer:a prospective study with intraoperative confirmation.Acta Radiol 2007;48:369-378[PMID:17453514 DOI:10.1080/02841850701294560]
73 Fong Y,Saldinger PF,Akhurst T,Macapinlac H,Yeung H,Finn RD,Cohen A,Kemeny N,Blumgart LH,Larson SM.Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.Am J Surg 1999;178:282 -287[PMID:10587184 DOI:10.1016/S0002-9610(99)00187-7]
74 Sahani DV,Kalva SP,Fischman AJ,Kadavigere R,Blake M,Hahn PF,Saini S.Detection of liver metastases from adenocarcinoma of the colon and pancreas:comparison of mangafodipir trisodiumenhanced liver MRI and whole-body FDG PET.AJR Am J Roentgenol 2005;185:239-246[PMID:15972430 DOI:10.2214/ajr.185.1.01850239]
75 Badiee S,Franc BL,Webb EM,Chu B,Hawkins RA,Coakley F,Singer L.Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases.AJR Am J Roentgenol 2008;191:1436-1439[PMID:18941082 DOI:10.2214/AJR.07.3750]
76 Revheim ME,Haugvik SP,Johnsrud K,Mathisen?,Fjeld JG,Skretting A.Respiratory gated and prolonged acquisition18 F-FDG PET improve preoperative assessment of colorectal liver metastases.Acta Radiol 2015;56:397-403[PMID:24682406DOI:10.1177/0284185114529563]
77 Ruers TJ,Wiering B,van der Sijp JR,Roumen RM,de Jong KP,Comans EF,Pruim J,Dekker HM,Krabbe PF,Oyen WJ.Improved selection of patients for hepatic surgery of colorectal liver metastases with(18)F-FDG PET:a randomized study.J Nucl Med 2009;50:1036-1041[PMID:19525451 DOI:10.2967/jnumed.109.063040]
78 Mainenti PP,Salvatore B,D’Antonio D,De Falco T,De Palma GD,D’Armiento FP,Bucci L,Pace L,Salvatore M.PET/CT colonography in patients with colorectal polyps:a feasibility study.Eur J Nucl Med Mol Imaging 2007;34:1594-1603[PMID:17492447 DOI:10.1007/s00259-007-0422-5]
79 Mainenti PP,Iodice D,Segreto S,Storto G,Magliulo M,De Palma GD,Salvatore M,Pace L.Colorectal cancer and 18FDGPET/CT:what about adding the T to the N parameter in locoregional staging?World J Gastroenterol 2011;17:1427-1433[PMID:21472100 DOI:10.3748/wjg.v17.i11.1427]
80 Maas M,Rutten IJ,Nelemans PJ,Lambregts DM,Cappendijk VC,Beets GL,Beets-Tan RG.What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer?A meta-analysis:imaging for recurrent colorectal cancer.Eur J Nucl Med Mol Imaging 2011;38:1560-1571[PMID:21468765 DOI:10.1007/s00259-011-1785-1]
81 Giacomobono S,Gallicchio R,Capacchione D,Nardelli A,Gattozzi D,Lettini G,Molinari L,Mainenti P,Cammarota A,Storto G.F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer.Int J Colorectal Dis 2013;28:1699-1705[PMID:23846517 DOI:10.1007/s00384-013-1747-0]
82 Storto G,Nicolai E,Salvatore M.[18F]FDG-PET-CT for early monitoring of tumor response:when and why.Q J Nucl Med Mol Imaging 2009;53:167-180[PMID:19293765]
83 Partovi S,Kohan A,Gaeta C,Rubbert C,Vercher-Conejero JL,Jones RS,O’Donnell JK,Wojtylak P,Faulhaber P.Image quality assessment of automatic three-segment MR attenuation correction vs.CT attenuation correction.Am J Nucl Med Mol Imaging 2013;3:291 -299[PMID:23638340]
84 Schwenzer NF,Schmidt H,Claussen CD.Whole-body MR/PET:applications in abdominal imaging.Abdom Imaging 2012;37:20 -28[PMID:22002195 DOI:10.1007/s00261-011-9809-7]
85 Drzezga A,Souvatzoglou M,Eiber M,Beer AJ,Fürst S,MartinezM?ller A,Nekolla SG,Ziegler S,Ganter C,Rummeny EJ,Schwaiger M.First clinical experience with integrated wholebody PET/MR:comparison to PET/CT in patients with oncologic diagnoses.J Nucl Med 2012;53:845-855[PMID:22534830 DOI:10 .2967/jnumed.111.098608]
86 Quick HH,von Gall C,Zeilinger M,Wiesmüller M,Braun H,Ziegler S,Kuwert T,Uder M,D?rfler A,Kalender WA,Lell M.Integrated whole-body PET/MR hybrid imaging:clinical experience.Invest Radiol 2013;48:280-289[PMID:23442775DOI:10.1097/RLI.0b013e3182845a08]
87 Partovi S,Kohan A,Paspulati RM,Ros PR,Herrmann KA.PET/MRI in Colorectal cancer.In:Carrio I,Ros P.PET/MRI Methodology and Clinical Applications.Springer 2014;7:95-108
88 Kershah S,Partovi S,Traughber BJ,Muzic RF,Schluchter MD,O’Donnell JK,Faulhaber P.Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.Mol Imaging Biol 2013;15:776-785[PMID:23632951 DOI:10.1007/s11307-013-0629-8]
89 Nielsen K,Scheffer HJ,Pieters IC,van Tilborg AA,van Waesberghe JH,Oprea-Lager DE,Meijerink MR,Kazemier G,Hoekstra OS,Schreurs HW,Sietses C,Meijer S,Comans EF,van den Tol PM.The use of PET-MRI in the follow-up after radiofrequency-and microwave ablation of colorectal liver metastases.BMC Med Imaging2014;14:27[PMID:25103913 DOI:10.1186/1471-2342-14-27]
90 Sheafor DH,Killius JS,Paulson EK,De Long DM,Foti AM,Nelson RC.Hepatic parenchymal enhancement during triple-phase helical CT:can it be used to predict which patients with breast cancer will develop hepatic metastases?Radiology 2000;214:875 -880[PMID:10715061]
91 Miles KA,Colyvas K,Griffiths MR,Bunce IH.Colon cancer:risk stratification using hepatic perfusion CT.Eur Radiol 2004;14(Suppl 2):129
92 Ridge JA,Bading JR,Gelbard AS,Benua RS,Daly JM.Perfusion of colorectal hepatic metastases.Relative distribution of flow from the hepatic artery and portal vein.Cancer 1987;59:1547-1553[PMID:3828954]
93 Leen E,Goldberg JA,Robertson J,Sutherland GR,Mc Ardle CS.The use of duplex sonography in the detection of colorectal hepatic metastases.Br J Cancer 1991;63:323-325[PMID:1997115]
94 Leen E,Goldberg JA,Robertson J,Sutherland GR,Hemingway DM,Cooke TG,Mc Ardle CS.Detection of hepatic metastases using duplex/color Doppler sonography.Ann Surg 1991;214:599 -604[PMID:1953113]
95 Kopljar M,Brkljacic B,Doko M,Horzic M.Nature of Doppler perfusion index changes in patients with colorectal cancer liver metastases.J Ultrasound Med 2004;23:1295-1300[PMID:15448318]
96 Anzidei M,Napoli A,Zaccagna F,Cartocci G,Saba L,Menichini G,Cavallo Marincola B,Marotta E,Di Mare L,Catalano C,Passariello R.Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy:evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.J Comput Assist Tomogr 2011;35:690 -696[PMID:22082538 DOI:10.1097/RCT.0b013e318230d905]
97 Meijerink MR,van Waesberghe JH,van der Weide L,van den Tol P,Meijer S,van Kuijk C.Total-liver-volume perfusion CT using3 -D image fusion to improve detection and characterization of liver metastases.Eur Radiol 2008;18:2345-2354[PMID:18491094DOI:10.1007/s00330-008-0996-8]
98 Kanematsu M,Goshima S,Watanabe H,Kondo H,Kawada H,Noda Y,Moriyama N.Diffusion/perfusion MR imaging of the liver:practice,challenges,and future.Magn Reson Med Sci 2012;11 :151-161[PMID:23037559]
99 De Bruyne S,Van Damme N,Smeets P,Ferdinande L,Ceelen W,Mertens J,Van de Wiele C,Troisi R,Libbrecht L,Laurent S,Geboes K,Peeters M.Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases.Br J Cancer 2012;106 :1926-1933[PMID:22596235 DOI:10.1038/bjc.2012.184]
100 Ganeshan B,Miles KA,Young RC,Chatwin CR.Texture analysisin non-contrast enhanced CT:impact of malignancy on texture in apparently disease-free areas of the liver.Eur J Radiol 2009;70:101 -110[PMID:18242909 DOI:10.1016/j.ejrad.2007.12.005]
101 Miles KA,Ganeshan B,Griffiths MR,Young RC,Chatwin CR.Colorectal cancer:texture analysis of portal phase hepatic CT images as a potential marker of survival.Radiology 2009;250:444 -452[PMID:19164695 DOI:10.1148/radiol.2502071879]
102 Rao SX,Lambregts DM,Schnerr RS,van Ommen W,van Nijnatten TJ,Martens MH,Heijnen LA,Backes WH,Verhoef C,Zeng MS,Beets GL,Beets-Tan RG.Whole-liver CT texture analysis in colorectal cancer:Does the presence of liver metastases affect the texture of the remaining liver?United European Gastroenterol J 2014;2:530-538[PMID:25452849 DOI:10.1177/2050640614552463]
103 Ganeshan B,Miles KA.Quantifying tumour heterogeneity with CT.Cancer Imaging 2013;13:140-149[PMID:23545171 DOI:10 .1102/1470-7330.2013.0015]
104 Barash H,Gross E,Edrei Y,Pappo O,Spira G,Vlodavsky I,Galun E,Matot I,Abramovitch R.Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia.Hepatology 2008;48:1232-1241[PMID:18629804 DOI:10.1002/hep.22394]
105 Barash H,Gross E,Matot I,Edrei Y,Tsarfaty G,Spira G,Vlodavsky I,Galun E,Abramovitch R.Functional MR imaging during hypercapnia and hyperoxia:noninvasive tool for monitoring changes in liver perfusion and hemodynamics in a rat model.Radiology 2007;243:727-735[PMID:17463135]
106 Edrei Y,Gross E,Corchia N,Tsarfaty G,Galun E,Pappo O,Abramovitch R.Vascular profile characterization of liver tumors by magnetic resonance imaging using hemodynamic response imaging in mice.Neoplasia 2011;13:244-253[PMID:21390187]
107 Edrei Y,Freiman M,Sklair-Levy M,Tsarfaty G,Gross E,Joskowicz L,Abramovitch R.Quantitative functional MRI biomarkers improved early detection of colorectal liver metastases.J Magn Reson Imaging 2014;39:1246-1253[PMID:24006217DOI:10.1002/jmri.24270]
108 Seo HJ,Kim MJ,Lee JD,Chung WS,Kim YE.Gadoxetate disodium-enhanced magnetic resonance imaging versus contrastenhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.Invest Radiol 2011;46:548-555[PMID:21577131DOI:10.1097/RLI.0b013e31821a2163]
109 Muhi A,Ichikawa T,Motosugi U,Sou H,Nakajima H,Sano K,Sano M,Kato S,Kitamura T,Fatima Z,Fukushima K,Iino H,Mori Y,Fujii H,Araki T.Diagnosis of colorectal hepatic metastases:comparison of contrast-enhanced CT,contrast-enhanced US,superparamagnetic iron oxide-enhanced MRI,and gadoxetic acidenhanced MRI.J Magn Reson Imaging 2011;34:326-335[PMID:21780227 DOI:10.1002/jmri.22613]
110 Zech CJ,Grazioli L,Jonas E,Ekman M,Niebecker R,Gschwend S,Breuer J,J?nsson L,Kienbaum S.Health-economic evaluation of three imaging strategies in patients with suspected colorectalliver metastases:Gd-EOB-DTPA-enhanced MRI vs.extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany,Italy and Sweden.Eur Radiol 2009;19 Suppl 3:S753-S763[PMID:19484243 DOI:10.1007/s00330-009-1432-4]
111 Chen L,Zhang J,Zhang L,Bao J,Liu C,Xia Y,Huang X,Wang J.Meta-analysis of gadoxetic acid disodium(Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases.PLo S One 2012;7:e48681[PMID:23144927 DOI:10 .1371/journal.pone.0048681]
112 Maffione AM,Lopci E,Bluemel C,Giammarile F,Herrmann K,Rubello D.Diagnostic accuracy and impact on management of(18)F-FDG PET and PET/CT in colorectal liver metastasis:a metaanalysis and systematic review.Eur J Nucl Med Mol Imaging 2015;42 :152-163[PMID:25319712 DOI:10.1007/s00259-014-2930-4]
113 Han K,Park SH,Kim KW,Kim HJ,Lee SS,Kim JC,Yu CS,Lim SB,Joo YS,Kim AY,Ha HK.Use of liver magnetic resonance imaging after standard staging abdominopelvic computed tomography to evaluate newly diagnosed colorectal cancer patients.Ann Surg 2015;261:480-486[PMID:24866542]
114 National Comprehensive Cancer Network Oncologic Guidelines.Colon cancer.Version 2.2012.Available from:URL:http://nccn.org
115 Sahani D,Mehta A,Blake M,Prasad S,Harris G,Saini S.Preoperative hepatic vascular evaluation with CT and MR angiography:implications for surgery.Radiographics 2004;24:1367-1380[PMID:15371614DOI:10.1148/rg.245035224]
116 Therasse P,Arbuck SG,Eisenhauer EA,Wanders J,Kaplan RS,Rubinstein L,Verweij J,Van Glabbeke M,van Oosterom AT,Christian MC,Gwyther SG.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Natl Cancer Inst 2000;92:205-216[PMID:10655437 DOI:10.1093/jnci/92.3.205]
117 Catenacci DV,Kozloff M,Kindler HL,Polite B.Personalized colon cancer care in 2010.Semin Oncol 2011;38:284-308[PMID:21421118]
118 Chibaudel B,Maindrault-Goebel F,Lledo G,Mineur L,AndréT,Bennamoun M,Mabro M,Artru P,Carola E,Flesch M,Dupuis O,Colin P,Larsen AK,Afchain P,Tournigand C,Louvet C,de Gramont A.Can chemotherapy be discontinued in unresectable metastatic colorectal cancer?The GERCOR OPTIMOX2 Study.J Clin Oncol 2009;27:5727-5733[PMID:19786657 DOI:10.1200/JCO.2009.23.4344]
119 Chung WS,Park MS,Shin SJ,Baek SE,Kim YE,Choi JY,Kim MJ.Response evaluation in patients with colorectal liver metastases:RECIST version 1.1 versus modified CT criteria.AJR Am J Roentgenol 2012;199:809-815[PMID:22997372]
120 Schima W,Ba-Ssalamah A,Kurtaran A,Schindl M,Gruenberger T.Post-treatment imaging of liver tumours.Cancer Imaging 2007;7Spec No A:S28-S36[PMID:17921098 DOI:10.1102/1470-7330.2007.9047]
